TONIX PHARMACEUTICALS HOLDING CORP.
Chatham
About TONIX PHARMACEUTICALS HOLDING CORP.
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $336.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:TNXP
- Website: tonixpharma.com
- Phone: (862)-799-8599
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tonix-pharmaceuticals-holding-corp-84710 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.